Should I buy Raymond James Financial (RJF) stock or is it too late?

Raymond James Financial · Financials · price $157

See the full Raymond James Financial (RJF) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Argus Research — 79% of its targets hit on this sector (124 calls tested). It aims for $196 (+25 %), call made on July 31, 2026, maturing on July 31, 2027 (75 d ago).

The 10 reliable analysts $176+12 %

The 1 other firm $205+31 %

How to read it: the 10 reliable firms are not filtered by optimism — 10 aim above the price, 0 below, hence their $176 median. “The 1 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Raymond James Financial

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Morgan Stanley	90 %	+26.0 %	20	$171 +9%
JMP Securities	78 %	+20.3 %	18	$190 +21%
Citigroup	50 %	+7.5 %	8	$180 +15%
Wells Fargo	67 %	-3.1 %	12	$172 +10%
Goldman Sachs	80 %	+15.4 %	5	—

In short — Should you invest in Raymond James Financial? Is it too late, still worth it? Analysts are split (27% buy, median target $179, i.e. +14%), and the most reliable on RJF targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $179, i.e. +14% from the current price ($157).
The most reliable firm on RJF, JP Morgan (100% hit rate, 2 scored calls), targets $185 (call made on October 5, 2026, maturing on October 5, 2027) (+18%) in its most recent call, and $180 (call made on October 23, 2025, maturing on October 23, 2026) (+15%) in the one coming due soonest.
Pays a dividend (1.7% yield) — regular income on top of potential upside.
Reasonable valuation (P/E ~14) relative to its sector.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 11 ratings, 8 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on RJF

Median target $179 (+14%) · 11 ratings · Hold consensus

Strong Buy00%

Buy327%

Hold873%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Raymond James Financial now?

We won't decide for you. The facts: 27% of analysts rate it a buy, median target $179 (+14%), and JP Morgan (most reliable on RJF, 100%) targets $185. Weigh that against valuation (P/E ~14). This is not personalized advice.

Is it too late to invest in Raymond James Financial?

Not according to analysts: the median target ($179) is still +14% above the current price ($157) (most reliable on RJF: JP Morgan, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Raymond James Financial still worth investing in?

It depends on the gap between the price ($157) and its estimated value: analysts target $179 on median (+14%), with 27% buys (most reliable on RJF: JP Morgan, 100%). Cross-check with their real reliability on RJF and the cautions above. Information, not advice.

What's the main risk in buying RJF?

The consensus is not unanimous: of 11 ratings, 8 are neutral.

→ Go deeper: the full Raymond James Financial profile (consensus, analyst reliability, price target, performance).